*Facility ID:*Event #: *Patient ID:Social Security #: Secondary ID: Patient Name, Last: First: Middle: *Gender: F M Other *Date of Birth: Ethnicity (specify):Race.

Slides:



Advertisements
Similar presentations
The Pharmaceutical Agent Order. Prescription An oral or written record of a physicians order to pharmacist to dispense medication to patient.
Advertisements

Influenza Vaccine Considerations Season
Protection of privacy for all Students!
Facility ID:________________Event#_________________________ *Patient ID:_____________________ Social Security#: __ __ __ - __ __ - __ __ __ __ Secondary.
Vaccines and Related Biological Products
National Cancer Institute Cancer Therapy Evaluation Program (CTEP) presents: How to Obtain Protected Health Information (PHI) from an Outside Healthcare.
H1N1 Vaccination Training for EMS State of Wisconsin Emergency Medical Services Charles E. Cady, MD State Medical Director Special thanks to Gateway Technical.
Introduction Director’ s Welcom e INFLUENZA Department of Defense Seasonal Influenza Vaccination Program Leaders Briefing UNCLASSIFIED.
Administration by Emergency Medical Services Personnel
Facility ID#:____________________________*Survey Year:_____________ A. Facility Information *1.Ownership of your dialysis center (choose one): □ Government.
Introduction to the National Healthcare Safety Network (NHSN) Richard Rodriguez, MPH Connecticut Department of Public Health 4/9/2014 Thank you to CDC.
INFLUENZA VACCINE CONSIDERATIONS SEASON Alicia Vanden Bosch, PharmD Creighton University SPAHP September,
Influenza and Influenza Vaccine
Content Management Portal PRA Disclosure Statement According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection.
NAVY DISEASE REPORTING SYSTEM INTERNET (DRSI) Navy and Marine Corps Public Health Center (June 2012)
Copyright 2003, Elsevier Science (USA). All rights reserved. Chapter 26 The Patient Record Copyright 2003, Elsevier Science (USA). All rights reserved.
Adult Immunization 2010 Influenza Segment This material is in the public domain This information is valid as of May 25, 2010.
Content Management Portal PRA Disclosure Statement According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection.
Health Insurance Portability and Accountability Act (HIPAA)
Assessing the Impact of a Toll-Free Number for Reporting Side Effects in Direct-to-Consumer Television Ads: Proposed Study Design Kathryn J. Aikin, Ph.D.
DATA PROTECTION AND PATIENT CONFIDENTIALITY IN RESEARCH Nic Drew Data Protection Manager University Hospital of Wales   
The following are instructions for public health officials and hospital users to conduct syndromic surveillance on influenza-like illnesses using ESSENCE.
Facility ID#: *HCW ID#:Social Security #: Secondary ID#: HCW Name, Last: First: Middle: Street Address: City:State:Zip Code: Home Phone: ( ) Address:
EMPLOYEE INFLUENZA VACCINATON. Influenza Vaccination (Your institution) is committed to keep both its employees and patients safe (Your institution) recognizes.
Saturday, October 24 And Saturday, November Kaiser Permanente Seasonal Flu Clinics Copyright © All rights reserved.
Healthcare Personnel Safety Component Healthcare Personnel Vaccination Module Influenza Vaccination Summary Ambulatory Surgery Centers National Center.
C#OMPANY LOGO OMB Control Number HealthCare.gov Data Collection August 31, 2010 Training.
Institutional Review Board (IRB) Human Subject Dr. John N. Austin, Director and Ms. Renee S. Jones, Associate Director Delaware State University Office.
CMS-Mandated Immunization Screening: Next Steps. Accomplishments 1.Immunization Screening section of Admit History is “smarter”. If patient has documented.
Influenza Update September 2015
CTS HIV Test Request Forms Training. Overview Introduction Introduction Explore new form Explore new form Practice Practice.
Facility ID: Vaccination #: Healthcare Worker Demographics *HCW ID#: HCW Name, Last:First:Middle: *Gender:  F  M *Date of Birth: *Work Location: *Occupation:
Texas Immunization Branch Influenza Update July 24 th, 2008.
SEASON INFLUENZA ITV Training Presented by: Janet Overstreet DPH/AFM/LHO August 20, :00-3:30pm 1.
Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (Q-Pan H5N1 Vaccine) Manufactured by GlaxoSmithKline Vaccines and Related Biological Products Advisory.
1 Vaccines and Related Biologic Products Advisory Committee (VRBPAC) May 16, 2007 FluMist ® Influenza Virus Vaccine Live, Intranasal Safety and Effectiveness.
INFLUENZA UPDATE DEBBYE ROSEN ADULT IMMUNIZATION COORDINATOR CONNECTICUT DEPARTMENT OF PUBLIC HEALTH
Immunization Update 2007 Satellite Broadcast/Webcast August 9, 2007 Influenza Vaccine Segment Graphics subject to change. This material in the public domain.
VETERANS HEALTH ADMINISTRATION SLIDE 0 New Requirements for VA ORD Investigators: Implementation of Data Management and Access Plans.
Tracing Requirements AT06 Slide 1. Identification of Ammunition  Essential information Type Calibre Model Lot and Batch Number AT06 Slide 2.
Facility ID:Event #: *Patient ID:Social Security #: Secondary ID: Patient Name, Last: First: Middle: *Gender: F M*Date of Birth: Ethnicity (specify):Race.
*Facility ID # : __________*Event # : __________ *Patient ID # : _____________ Social Security # : ___ ___ ___ - ___ ___ - ___ ___ ___ ___ Secondary ID.
*Facility ID:*Event #: *Patient ID:Social Security #: Secondary ID: Patient Name, Last: First: Middle: *Gender: F M*Date of Birth: Ethnicity (specify):Race.
Scott Van Heest IT Specialist NAACCR 2010, Quebec City, Canada June 24, 2010 Central Cancer Registry: Data Security The Reporting of Veterans Health Administration.
1 BSO Welcome. 2 General Login Attestation 3 BSO Login.
Warning Signs Y es No Unk Persistent Vomiting…………..... Abdominal pain/Tenderness.. Mucosal Bleeding …………….. Lethargy, restlessness……….… Liver Enlargement.
* required for saving Tracking #: Facility ID:*Survey Year: Facility Characteristics *Ownership (check one): □ For profit □ Not for profit, including church.
*Facility ID # : _____________ *HCW ID # : _____________ Social Security # : ___ ___ ___ - ___ ___ - ___ ___ ___ ___ Secondary ID # : _____________ HCW.
Purposes of NHSN Participation in the NHSN reflects the individual facility’s need for high quality and timely data on adverse events and adherence to.
Vaccination Info. Journal of immunology Vaccination of HCWs was associated with reductions in total patient mortality from 17% to 10% (odds ratio [OR],
National Hospital Care Survey (NHCS). 2 Overview What is the National Center for Health Statistics (NCHS)? What is the National Hospital Care Survey (NHCS)?
[Presentation location] [Presentation date] (Confirm ABT logo) Building Bridges and Bonds (B3): An introduction.
Facility ID#: Med Admin#: Healthcare Worker Demographics *HCW ID#: *HCW Name, Last:First:Middle: *Gender:  F  M  Other *Date of Birth:// *Work Location:*Occupation:
A.Facility Information: Facility ID: __________ 1.Ownership of your dialysis center (choose one): ____For profit ____Not for profit ____Government 2. Location.
The Alien Flight Student Program AFSP An overview of the applications that encompass the AFSP Program COPYRIGHT AND GOVERNMENT PURPOSE RIGHTS NOTICE Copyright.
Evidence-Based Practice Working Group Focus Group Guide NCCCP Experiences with Using/Implementing the Template for Community Outreach (TCO) Brenda Adjei,
Assurance of Confidentiality: The information obtained in this surveillance system that would permit identification of any individual or institution is.
National Hospital Care Survey (NHCS) Acute Coronary Syndrome Study.
Thank you very much for including the HD*Calc software ( on your website or social media platform. The National Cancer Institute.
Facility ID:Procedure #: *Patient ID:Social Security #: Secondary ID: Patient Name, Last: First: Middle: *Gender: F M*Date of Birth: Ethnicity (specify):Race.
Brady Act Requirements In November 1993, the Brady Handgun Violence Prevention Act of 1993 (Brady Act), Public Law , was signed into law requiring.
OMB Control No , Expires on: 11/30/2014.
DENGUE CASE INVESTIGATION REPORT CDC Dengue Branch and Puerto Rico Department of Health 1324 Calle Cañada, San Juan, P. R Tel. (787) ,
Facility Information: *Facility Name: __________________________________________________________________ *Main Telephone Number: ( ) ______-____________.
ACIP Recommendations Update for the U.S. Influenza Season
You will be given your form which looks like this.
Stakeholder Monthly Webinar
How we use Your Health Records
Recording & Data Collection
Influenza algorithm for determining recommended 2009–2010 influenza immunization. a Contraindications: please refer to page 7 of the policy statement for.
Presentation transcript:

*Facility ID:*Event #: *Patient ID:Social Security #: Secondary ID: Patient Name, Last: First: Middle: *Gender: F M Other *Date of Birth: Ethnicity (specify):Race (specify): *Event Type: FLUVAX *Influenza subtype:  Seasonal  Non-Seasonal *Date Admitted to Facility: *Vaccine offered:  Yes  No *Vaccine declined:  Yes  No Reason(s) vaccine declined (Check either section A or B but not both) A. Medical contraindication(s) (check all that apply): B. Personal reason(s) for declining (check all that apply):  Allergy to vaccine components  History of Guillian-Barre syndrome within 6 weeks of previous influenza vaccination  Current febrile illness (Temp > 101.5°F)  Other (specify): ____________________________  Fear of needles/injections  Fear of side effects  Perceived ineffectiveness of vaccine  Religious or philosophical objections  Concern for transmitting vaccine virus to contacts  Other (specify): _________________________ *Vaccine administered:  Yes  No ^Date Vaccine Administered: ^Type of influenza vaccine administered: Seasonal:  Afluria ®  Agriflu ®  Fluarix ®  FluLaval ®  Flumist ®  Fluvirin ®  Fluzone ®  Fluzone High-Dose ®  Other (specify) ____________________ Non-seasonal:  Other (specify) _____________________________  Live attenuated influenza vaccine (LAIV) e.g., nasal  Inactivated vaccine (TIV) ^Manufacturer: _____________________________ ^Lot number: _______________________ ^Route of administration:  Intramuscular  Intranasal  Subcutaneous Vaccine Information Statement (VIS) Provided to Patient:  Live Attenuated Influenza VIS  Inactivated Influenza VIS  None or unknown Edition Date: ________/_________/________ Person Administering Vaccine: Vaccinator ID:Title: Name: Last: First: Middle: Work Address: _________________________________________________________________________ City:_____________________________ State: _________________________ Zip code: _____________ Assurance of Confidentiality: The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)). Public reporting burden of this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS D-74, Atlanta, GA 30333, ATTN: PRA ( ). CDC rev 3, v 6.4 Patient Vaccination * required for saving ^ conditionally required Page 1 of 2 OMB No Exp. Date:

Custom Fields Label ________________________ ___/___/____ ________________________ ____________ Label ________________________ ___/___/____ ________________________ ____________ Comments Patient Vaccination CDC (Back) Rev. 3, v6.4 Page 2 of 2 OMB No Exp. Date: